Probe Array definition

Probe Array means a solid support having an array of polynucleotides with known location and sequence fabricated by or for and sold by Affymetrix for use in expression analysis and genotyping and shall include all probe arrays generally offered by Affymetrix for commercial sale during the Term as well as arrays available through Affymetrix' current CustomExpress®, NimbleExpress™ and Made-to-Order programs, as well as resequencing arrays available through Affymetrix' current CustomSeq® program, including those now available as indicated on Exhibits 1. Such arrays must be purchased in whole wafer increments unless otherwise indicated in Exhibits 1. All other custom arrays/array designs will be mutually agreed to in writing between the Parties in advance.
Probe Array means a solid support having an array of polynucleotides with known location and sequence fabricated by Affymetrix pursuant to this Agreement for use in expression analysis.
Probe Array means arrays that consist of a support on which nucleic acid probes are attached directly or indirectly (e.g. using beads) as single molecules or localized groups of replicas, with each usable probe having a known or determined nucleic acid sequence and known position on the support so that the position on the support can be used in an assay to identify the nucleic acid probe. Locations of probe attachment sites or probe position assignment may be random or in the form of a predefined pattern. As a clarification, Probe Arrays can be prepared by random probe assignment to probe positions and determination of which probe is in which position by sequencing or otherwise identifying the sequences of the attached probes. Some positions may have unusable nucleic acid probe with undetermined and/or unknown sequence. Usable probes may have degenerate bases.

Examples of Probe Array in a sentence

  • After Affymetrix determines [***] the feasibility of the manufacture of New Process Custom Probe Arrays pursuant to the Work Plan, N-Mer shall have the right to order its requirements of New Process Custom Probe Arrays from Affymetrix, provided that in such orders N-Mer will identify probe sequences for each New Process Custom Probe Array [***].

  • Buyer agrees that third parties may only receive data from Expression Probe Array Data under (c)(i)-(iii) hereof pursuant to written agreements containing obligations explicitly benefitting AFX that are no less restrictive than those in this Agreement and which require such third party recipients not to sublicense or further distribute or transfer such data.

  • For each Probe Array delivered to N-Mer or its Affiliates for distribution to end users, N-Mer shall pay Affymetrix according to the following formula: PER UNIT PROBE ARRAY PRICE = [***] where [***] is calculated under general accepted accounting principles as applied by [***].

  • For each Custom Probe Array delivered to N-Mer or its Affiliates for researching and developing products in the N-MER Field, N-Mer will pay Affymetrix its then current Cost plus [***] for such Probe Arrays.

  • Buyer is not licensed to, and agrees not to: (a) resell any AFX-supplied Probe Array, reagent or other Product, (b) transfer or distribute any AFX-supplied Probe Array, reagent or other Product, directly or indirectly, to any third party for any purpose or use, except as otherwise approved by AFX in writing; (c) use or allow anyone to use any AFX-supplied Probe Array or reagent more than once, or dilute any AFX-supplied reagent.

  • BMX shall have responsibility for over-all system planning and development, including, without limitation, instrument development, integrated device development, amplification technology development, DNA Probe Array packaging, regulatory approval and marketing, and shall use commercially reasonable efforts to commercialize products pursuant to this Agreement.

  • EXHIBIT C Expression Probe Array Use Rights for Service Recipients and Database Subscribers RESTRICTED USE RIGHTS- Purchasers of Services or Database subscribers pursuant to this Agreement ("Buyer") may only use the data from Expression Probe Array services provided hereunder to identify the presence and/or levels of expressed nucleic acid sequences in the ordinary course of Buyer's normal internal pharmaceutical and diagnostic research and development activities, including clinical trials.

  • All requests by Buyer for replacement of defective Probe Arrays shall consist of an itemized list of the allegedly defective Probe Arrays, including Probe Array type, array lot number, defect classification, expiration date and any other information reasonably deemed pertinent to assist AFX with ongoing quality improvement.

  • In a manner responsive to over-all planning needs, AFFX shall assume primary responsibility for DNA Probe Array manufacturing process development and DNA Probe Array production, and the Parties shall share the tasks of Probe selection, DNA Probe Array design, optimization and assay development.

  • In the event that Buyer requests replacement for Probe Arrays in excess of [REDACTED] percent ([REDACTED]%) of the Probe Arrays scanned by Buyer during any one quarterly period, then such Probe Array replacements in excess of [REDACTED] percent ([REDACTED] %) will be subject to the AFX’ Replacement Policy as set forth in Exhibit 7 of the Service Provider Agreement.


More Definitions of Probe Array

Probe Array means a solid support having an array of polynucleotides with known [***] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.
Probe Array means an array of diverse nucleic acids or polynucleotides at defined locations on a single solid support which is claimed or covered by (x) patents or patent applications, (y) any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates or the like, or any provisional applications, of any such patents or patent applications, or (z) any foreign or international equivalent of any of the foregoing, in each case owned by or exclusively licensed to Affymetrix or its Affiliates as of the Effective Date or acquired or developed after the Effective Date independent of all of the Research Programs and Product Development Programs.
Probe Array means a single Solid Support having affixed thereto oligonucleotide, including nucleic acid, probes [***]; provided that [***] are excluded.
Probe Array means a single Solid Support having affixed thereto oligonucleotide, including nucleic acid, probes [***]; provided that [***]. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
Probe Array means a solid support having an array of polynucleotides with known location and sequence fabricated by Affymetrix pursuant to this Agreement for use in [***] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. -4-

Related to Probe Array

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • API means American Petroleum Institute.

  • Bioassay means the determination of kinds, quantities or concentrations, and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these regulations, "radiobioassay" is an equivalent term.

  • Novartis shall have the meaning set forth in the Preamble.

  • GSK or ‘𝐺𝑆𝐾’ means the generation shift key as defined in Article 2(12) of the CACM Regulation;